These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7295513

  • 1. Resistance to the cytocidal effects of adriamycin is an early phenotypic change induced during hepatocarcinogenesis.
    Carr BI, Laishes BA.
    Br J Cancer; 1981 Oct; 44(4):567-71. PubMed ID: 7295513
    [Abstract] [Full Text] [Related]

  • 2. Carcinogen-induced drug resistance in rat hepatocytes.
    Carr BI, Laishes BA.
    Cancer Res; 1981 May; 41(5):1715-9. PubMed ID: 6783299
    [Abstract] [Full Text] [Related]

  • 3. Experimental chemical hepatocarcinogenesis: early membrane changes of significance for drug resistance.
    Carr BI.
    J Cell Physiol Suppl; 1986 May; 4():59-63. PubMed ID: 3462192
    [Abstract] [Full Text] [Related]

  • 4. In vitro measurement of resistance to phalloidin and gamma-glutamyltransferase of carcinogen-induced preneoplastic hepatocytes of rats.
    Sawada N, Furukawa K, Tsukada H.
    J Natl Cancer Inst; 1982 Sep; 69(3):683-6. PubMed ID: 6125619
    [Abstract] [Full Text] [Related]

  • 5. Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats.
    Carr BI.
    Cancer Res; 1987 Nov 01; 47(21):5577-83. PubMed ID: 2889526
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM, Katayama S, Ohmori T.
    Carcinogenesis; 1981 Nov 01; 2(11):1111-7. PubMed ID: 6119166
    [Abstract] [Full Text] [Related]

  • 7. In vitro measurement of carcinogen-resistant liver cells during hepatocarcinogenesis.
    Laishes BA, Roberts E, Farber E.
    Int J Cancer; 1978 Feb 15; 21(2):186-93. PubMed ID: 627426
    [No Abstract] [Full Text] [Related]

  • 8. Distinctive biochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis.
    Eriksson L, Ahluwalia M, Spiewak J, Lee G, Sarma DS, Roomi MJ, Farber E.
    Environ Health Perspect; 1983 Mar 15; 49():171-4. PubMed ID: 6832091
    [Abstract] [Full Text] [Related]

  • 9. Modification of the development of N-nitrosomorpholine-induced hepatic lesions by 2-acetylaminofluorene, phenobarbital and 4,4'-diaminodiphenylmethane: a sequential histological and histochemical analysis.
    Ito N, Moore MA, Bannasch P.
    Carcinogenesis; 1984 Mar 15; 5(3):335-42. PubMed ID: 6705139
    [Abstract] [Full Text] [Related]

  • 10. Changes in levels of ADP-ribose polymers in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis.
    Kiehlbauch CC, Kosanke SD, Ringer DP.
    Carcinogenesis; 1993 Jul 15; 14(7):1435-40. PubMed ID: 8330362
    [Abstract] [Full Text] [Related]

  • 11. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.
    Solt DB, Medline A, Farber E.
    Am J Pathol; 1977 Sep 15; 88(3):595-618. PubMed ID: 18937
    [Abstract] [Full Text] [Related]

  • 12. Sequential functional and morphological alterations during hepatocarcinogenesis induced in rats by feeding of a low dose of 2-acetylaminofluorene.
    Stenbäck F, Gebhardt R, Sirma H, Garbay JM, Williams GM.
    Toxicol Pathol; 1994 Sep 15; 22(6):620-32. PubMed ID: 7732279
    [Abstract] [Full Text] [Related]

  • 13. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M, Tamura T, Kuroda J, Ohnota H, Shibata N, Akahane M, Kashida Y, Mitsumori K.
    Toxicol Sci; 2005 Mar 15; 84(1):22-8. PubMed ID: 15564315
    [Abstract] [Full Text] [Related]

  • 14. alpha-fetoprotein-containing cells in the early stages of liver carcinogenesis induced by 3'-methyl-4-dimethyl-aminoazobenzene and 2-acetylaminofluorene.
    Tchipysheva TA, Guelstein VI, Bannikov GA.
    Int J Cancer; 1977 Sep 15; 20(3):388-93. PubMed ID: 71280
    [Abstract] [Full Text] [Related]

  • 15. An experimental method for rapid growth of liver in spleen. The survival and proliferation of chemically induced preneoplastic hepatocytes in spleen.
    Finkelstein SD, Lee G, Medline A, Tatematsu M, Makowka L, Farber E.
    Am J Pathol; 1983 Feb 15; 110(2):119-26. PubMed ID: 6824060
    [Abstract] [Full Text] [Related]

  • 16. Fumonisin B1-induced hepatocellular and cholangiocellular tumors in male Fischer 344 rats: potentiating effects of 2-acetylaminofluorene on oval cell proliferation and neoplastic development in a discontinued feeding study.
    Lemmer ER, Vessey CJ, Gelderblom WC, Shephard EG, Van Schalkwyk DJ, Van Wijk RA, Marasas WF, Kirsch RE, Hall Pde L.
    Carcinogenesis; 2004 Jul 15; 25(7):1257-64. PubMed ID: 14988222
    [Abstract] [Full Text] [Related]

  • 17. Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells.
    Schrenk D, Gant TW, Michalke A, Orzechowski A, Silverman JA, Battula N, Thorgeirsson SS.
    Carcinogenesis; 1994 Nov 15; 15(11):2541-6. PubMed ID: 7955103
    [Abstract] [Full Text] [Related]

  • 18. Association between DNA strand breaks and specific DNA adducts in murine hepatocytes following in vivo and in vitro exposure to N-hydroxy-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene.
    Vu VT, Møller ME, Grantham PH, Wirth PJ, Thorgeirsson SS.
    Carcinogenesis; 1985 Jan 15; 6(1):45-52. PubMed ID: 4038475
    [Abstract] [Full Text] [Related]

  • 19. Glutamine synthetase heterogeneous expression as a marker for the cellular lineage of preneoplastic and neoplastic liver populations.
    Gebhardt R, Tanaka T, Williams GM.
    Carcinogenesis; 1989 Oct 15; 10(10):1917-23. PubMed ID: 2571426
    [Abstract] [Full Text] [Related]

  • 20. Transfer of viable putative preneoplastic hepatocytes to the livers of syngeneic host rats.
    Laishes BA, Farber E.
    J Natl Cancer Inst; 1978 Aug 15; 61(2):507-12. PubMed ID: 28422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.